Steven W Booth
Overview
Explore the profile of Steven W Booth including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
56
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
DeMatos L, Williams A, Booth S, Petts C, Taylor D, Blagden N
J Pharm Sci
. 2007 Apr;
96(5):1069-78.
PMID: 17455330
Solvent influences on the crystallization of polymorph and hydrate forms of the nootropic drug piracetam (2-oxo-pyrrolidineacetamide) were investigated from water, methanol, 2-propanol, isobutanol, and nitromethane. Crystal growth profiles of piracetam...
2.
Hardy I, Windberg-Baarup A, Neri C, Byway P, Booth S, Fitzpatrick S
Int J Pharm
. 2007 Feb;
337(1-2):246-53.
PMID: 17306477
Hydrophilic matrix tablets are widely used to extend the release of a broad range of pharmaceutically active materials. The mechanism and kinetics of drug release are dependent on the solubility...
3.
Fitzpatrick S, Taylor S, Booth S, Newton M
Pharm Dev Technol
. 2006 Nov;
11(4):521-8.
PMID: 17101523
A development program has been carried out to provide a stable extrusion/spheronisation pellet formulation for a highly water-soluble drug, sitagliptin, which undergoes a change in physical form on processing and...
4.
Williams A, Cooper V, Thomas L, Griffith L, Petts C, Booth S
Int J Pharm
. 2004 Apr;
275(1-2):29-39.
PMID: 15081136
An active pharmaceutical ingredient (API) was found to dissociate from the highly crystalline hydrochloride form to the amorphous free base form, with consequent alterations to tablet properties. Here, a wet...
5.
Hardy I, Fitzpatrick S, Booth S
J Pharm Pharmacol
. 2004 Jan;
55(12):1593-9.
PMID: 14738583
Tamp filling processes are widely used for the filling of powders into hard gelatin capsules, whereby capsule fill weight is controlled by the formation of a loosely packed plug of...
6.
Fitzpatrick S, McCabe J, Petts C, Booth S
Int J Pharm
. 2002 Sep;
246(1-2):143-51.
PMID: 12270617
Accelerated stability studies are a common approach for predicting the long-term stability of pharmaceutical formulations. However, in this study, a slowing of dissolution was observed for a formulation following storage...
7.
Campbell Roberts S, Williams A, Grimsey I, Booth S
J Pharm Biomed Anal
. 2002 Jun;
28(6):1149-59.
PMID: 12049979
Mannitol is a polymorphic parmaceutical excipient, which commonly exists in three forms: alpha, beta and delta. Each polymorph has a needle-like morphology, which can give preferred orientation effects when analysed...
8.
Campbell Roberts S, Williams A, Grimsey I, Booth S
J Pharm Biomed Anal
. 2002 Jun;
28(6):1135-47.
PMID: 12049978
Mannitol is a polymorphic excipient which is usually used in pharmaceutical products as the beta form, although other polymorphs (alpha and delta) are common contaminants. Binary mixtures containing beta and...